22-50482647-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001253845.2(ADM2):c.191G>A(p.Arg64Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000262 in 1,556,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001253845.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADM2 | NM_001253845.2 | c.191G>A | p.Arg64Gln | missense_variant | 3/3 | ENST00000395737.2 | NP_001240774.1 | |
ADM2 | NM_001369882.1 | c.191G>A | p.Arg64Gln | missense_variant | 2/2 | NP_001356811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADM2 | ENST00000395737.2 | c.191G>A | p.Arg64Gln | missense_variant | 3/3 | 1 | NM_001253845.2 | ENSP00000379086.1 | ||
ADM2 | ENST00000395738.2 | c.191G>A | p.Arg64Gln | missense_variant | 2/2 | 1 | ENSP00000379087.2 | |||
SBF1 | ENST00000685180.1 | n.131+1146C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000158 AC: 30AN: 190020Hom.: 0 AF XY: 0.000200 AC XY: 21AN XY: 104758
GnomAD4 exome AF: 0.000253 AC: 355AN: 1404024Hom.: 0 Cov.: 31 AF XY: 0.000270 AC XY: 187AN XY: 692096
GnomAD4 genome AF: 0.000341 AC: 52AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at